Novel combination including eftilagimod alfa (efti) in neoadjuvant setting drives 51.5% tumour hyalinization/fibrosis in patients with soft ...
Progression-free and overall survival outcomes in patients with cancer treated with immunotherapy could be related to thymic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback